42Stockpicking

ETON

Eton Pharmaceutcials Inc
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
EV/EBITDAi
P/Bi
25,6
94th %ile · 404p
P/Si
5,8
59th %ile · 356p
EV/Salesi
5,7
59th %ile · 356p
Div yieldi

Kursudvikling

Kun 95 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026none
Prishistorik
0,3 år
Pris-dage
76
Årsregnskaber
9
Peers
0/0
Valuation
3/6
Fundamentals
8/8
Datovindue
2026-02-11 til 2026-06-01

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,7 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

ETON vurderet 2026-06-10

Score
50.2%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

77%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

44%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

37%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

58%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

58%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

56%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
-393.340
Net 90d (værdi)
-14.795.352 USD
Købere 90d
0
Cluster
DatoPersonRolleTypeAntalVærdiKilde
20.8.2026BRYNJELSEN SEANPresident & CEO▼ SALG-47.307-2.846.462 USDsec
19.8.2026BRYNJELSEN SEANPresident & CEO▼ SALG-8.978-562.472 USDsec
14.7.2026Opaleye Management Inc.▼ SALG-15.000-563.147 USDsec
14.7.2026BRYNJELSEN SEANPresident & CEO◆ OPT.200.000274.000 USDsec
12.7.2026Krempa DavidChief Business Officer◆ OPT.10.000sec
12.7.2026BRYNJELSEN SEANPresident & CEO◆ OPT.27.500sec
7.7.2026Opaleye Management Inc.▼ SALG-20.000-767.456 USDsec
6.7.2026Opaleye Management Inc.▼ SALG-10.000-380.000 USDsec
2.7.2026Opaleye Management Inc.▼ SALG-65.000-2.430.032 USDsec
17.6.2026Adams Jennifer McKie◆ OPT.50.000189.000 USDsec
17.6.2026Adams Jennifer McKie▼ SALG-50.000-1.623.795 USDsec
28.5.2026BRYNJELSEN SEANPresident & CEO▼ SALG-119.852-3.820.882 USDsec
27.5.2026Krempa DavidChief Business Officer▼ SALG-19.679-619.375 USDsec
27.5.2026Krempa DavidChief Business Officer◆ OPT.12.47617.092 USDsec
26.5.2026Krempa DavidChief Business Officer◆ OPT.25.00034.500 USDsec
26.5.2026Krempa DavidChief Business Officer▼ SALG-37.524-1.181.732 USDsec
22.5.2026Krempa DavidChief Business Officer▼ SALG-32.963-1.095.057 USDsec
22.5.2026Krempa DavidChief Business Officer◆ OPT.30.591109.516 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.20260,140,14+0.0%+0.0%Inline
2025Q430.1.20260,190,20-5.0%-5.0%Miss
2025Q330.10.20250,040,16-75.0%-75.0%Miss
2025Q230.7.20250,030,02+28.6%+28.6%Beat